Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Toxicology Letters
|
December 8, 2009
Formaldehyde dehydrogenase: beyond phase I metabolism
Chad M Thompson, Rebecca Ceder, Roland C Grafström
Oral Oncology
|
May 16, 2009
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines
Anna Ansell, Fredrik Jerhammar, Rebecca Ceder, et al.
Differentiation; Research in Biological Diversity
|
May 3, 2008
Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture
Karin Roberg, Rebecca Ceder, Lovisa Farnebo, et al.
Cancer Biology & Therapy
|
October 9, 2010
Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma
Fredrik Jerhammar, Rebecca Ceder, Stina Garvin, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 1, 2014
Cancer biology, toxicology and alternative methods development go hand-in-hand
Pekka Kohonen, Rebecca Ceder, Ines Smit, et al.
EJIFCC
|
November 7, 2024
History, Implementation and Current Use of the IFCC-IUPAC's Nomenclature for Properties and Units (NPU) Terminology in Denmark, Norway and Sweden
Steen Antonsen, Erik Koldberg Amundsen, Rebecca Ceder, et al.
Cell Biology and Toxicology
|
May 12, 2016
Arsenic alters global histone modifications in lymphocytes in vitro and in vivo
Angeliki Pournara, Maria Kippler, Teresa Holmlund, et al.
Nature Communications
|
July 4, 2017
A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury
Pekka Kohonen, Juuso A Parkkinen, Egon L Willighagen, et al.
Plos One
|
January 14, 2012
CD44 expression in oro-pharyngeal carcinoma tissues and cell lines
Abirami Rajarajan, Angela Stokes, Balvinder K Bloor, et al.
Oral Oncology
|
July 5, 2014
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
Fredrik Jerhammar, Ann-Charlotte Johansson, Rebecca Ceder, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Toxicology Letters
|
December 8, 2009
Formaldehyde dehydrogenase: beyond phase I metabolism
Chad M Thompson, Rebecca Ceder, Roland C Grafström
Oral Oncology
|
May 16, 2009
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines
Anna Ansell, Fredrik Jerhammar, Rebecca Ceder, et al.
Differentiation; Research in Biological Diversity
|
May 3, 2008
Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture
Karin Roberg, Rebecca Ceder, Lovisa Farnebo, et al.
Cancer Biology & Therapy
|
October 9, 2010
Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma
Fredrik Jerhammar, Rebecca Ceder, Stina Garvin, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 1, 2014
Cancer biology, toxicology and alternative methods development go hand-in-hand
Pekka Kohonen, Rebecca Ceder, Ines Smit, et al.
EJIFCC
|
November 7, 2024
History, Implementation and Current Use of the IFCC-IUPAC's Nomenclature for Properties and Units (NPU) Terminology in Denmark, Norway and Sweden
Steen Antonsen, Erik Koldberg Amundsen, Rebecca Ceder, et al.
Cell Biology and Toxicology
|
May 12, 2016
Arsenic alters global histone modifications in lymphocytes in vitro and in vivo
Angeliki Pournara, Maria Kippler, Teresa Holmlund, et al.
Nature Communications
|
July 4, 2017
A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury
Pekka Kohonen, Juuso A Parkkinen, Egon L Willighagen, et al.
Plos One
|
January 14, 2012
CD44 expression in oro-pharyngeal carcinoma tissues and cell lines
Abirami Rajarajan, Angela Stokes, Balvinder K Bloor, et al.
Oral Oncology
|
July 5, 2014
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
Fredrik Jerhammar, Ann-Charlotte Johansson, Rebecca Ceder, et al.
Page
of 2